Health Law Regulatory Summary Navigator

Found 2753 Results
Filters
Location
Massachusetts (284)
Oregon (263)
Texas (250)
Washington (185)
Colorado (144)
Monitor Topic
Public Health (1000+)
Health Practitioner Licensing (760)
Medicaid (722)
Insurance (538)
Pharmaceuticals (515)
Narrow by Date
1 - 50
of
1000+
Results
Document
Jurisdiction
Monitor Topic
Publication Date
Summary
West Virginia Health Information and Technology, Insurance, Pharmaceuticals, Public Health 03/13/20 Notice of the Insurance Commission announces the issuance of Insurance Bulletin No. 2020-01 on the new coronavirus (Covid-19). The bulletin provides that health carriers should make information available on their websites; staff their nurse-help lines; waive any cost-sharing for Covid-19 laboratory tests; and waive the cost-sharing for in-network provider office visits, in-network urgent care center visits when testing for Covid-19, and emergency room visits when testing for Covid-19. The bulletin also provides that carriers should review and ensure their telehealth programs with participating providers are robust and will be able to meet any increased demand. In addition, the bulletin provides that carriers should make exceptions under certain circumstances to provide access to an out-of-network provider at the in-network cost-sharing; expedite utilization review and appeal processes for services related to Covid-19, when medically appropriate; and immediately cover future Covid-19 immunizations at no cost-sharing for all covered members. Finally, the bulletin provides that health carriers should ensure access to prescription drugs by making expedited formulary exceptions if needed and report to the department about actions taken in response to the bulletin. Contact: Ellen Potter; Insurance Commission; 304-414-8480
Oregon Clinical Labs, Medical Facility Licensing, Occupational safety and health, Pediatric Care, Public Health 09/11/20 Final rule of the Health Authority, Public Health Division, amends and adopts regulations under OAR 333-017 , -018, and -019 to require health care providers to report coronavirus (Covid-19) cases, hospitalizations, and deaths and cases of multi-system inflammatory syndrome in children. The rule also requires laboratory reporting of positive and negative Covid-19 test results and requires Covid-19 cases to be excluded from attendance or work in schools or children's facilities and from work in health care facilities or food service facilities. In addition, the rule requires health care facilities to adopt policies on restricting employees with Covid-19 or employees with substantial exposure to Covid-19. The rule is effective Sept. 4, 2020. Contact: Heather Owens; OHA, Public Health Division; 971-291-2568; heather.r.owens@dhsoha.state.or.us
Oregon Clinical Labs, Pharmaceuticals, Public Health 04/28/20 Temporary rule of the Health Authority adopts regulations under OAR 333-024 to allow coronavirus (Covid-19) testing at a waived laboratory, a pharmacy, or a pharmacy-sponsored facility. The rule also allows pharmacists employed by or contracted with a pharmacy or a pharmacy-sponsored facility with a waived laboratory license to perform Covid-19 tests to screen patients for Covid-19 tests, order and administer Covid-19 tests, and report the results of Covid-19 tests. The rule is effective April 23, 2020, and expires Oct. 19, 2020. Contact: Brittany Hall; OHA; 503-693-4100; publichealth.rules@state.or.us
Oregon Clinical Labs, Medical Facility Licensing, Occupational safety and health, Pediatric Care, Public Health 03/12/20 Temporary rule of the Health Authority, Public Health Division, adopts regulations under OAR 333-017 , -018, and -019 to require laboratories and health care providers to report both positive and negative tests for new coronavirus (Covid-19). The rule also prohibits individuals with Covid-19 from attending or working at a children's facilities, schools, food service facilities, or health care facilities and requires school administrators to restrict individuals from attending or working at children's facilities or schools, if the individual had substantial exposure to someone with Covid-19. In addition, the rule allows for the removal of restrictions by a statement of the local public health administrator or local health officer that the disease is no longer communicable to others or that adequate precautions have been taken to minimize the risk of transmission. Finally, the rule requires health care facilities to adopt policies regarding restrictions for employees with Covid-19 or employees with a substantial exposure to Covid-19. The rule is effective March 9, 2020, and expires Sept. 4, 2020. Contact: Brittany Hall; OHA, Public Health Division; 971-673-1111; publichealth.rules@state.or.us
Massachusetts Health Information and Technology, Medicaid, Medical Billing, Pharmaceuticals, Public Health 03/17/20 Notice of the Executive Office of Health and Human Services announces the issuance of All Provider Bulletin 289 to all providers participating in MassHealth regarding the new coronavirus (Covid-19). The bulletin specifies the codes that providers should use to billing for the testing, treatment, and prevention of Covid-19, including diagnostic laboratory services, telehealth, home visits, quarantine, and drugs. The bulletin also describes an expansion of hospital-determined presumptive eligibility procedures for individuals diagnosed with Covid-19. In addition, the bulletin addresses the lack of cost sharing and primary care referral requirements for Covid-19 services and allows enrollees to receive 90-day supplies and early refills of necessary prescriptions. The bulletin is issued in response to the March 10, 2020, state of emergency declaration. Contact: EOHHS; 800-841-2900; providersupport@mahealth.net
North Dakota Insurance, Public Health 05/20/20 Notice of the Insurance Department announces the issuance of Bulletin 2020-10 to insurance carriers offering health benefit plans and self-funded plans on coverage of antibody testing for coronavirus (Covid-19). The bulletin recommends that carriers remove barriers to testing by establishing dedicated help lines to respond to Covid-19 calls, relax prior approval and out-of-network requirements and procedures for medically necessary testing or treatment, and forego cost-sharing for medically necessary Covid-19 diagnostic testing, including influenza testing or other respiratory testing done in conjunction with Covid-19 testing. Contact: Insurance Department; 701-328-2440
Nevada Health Information and Technology, Insurance, Pharmaceuticals, Public Health 03/23/20 Emergency rule of the Commissioner of Insurance adopts regulations under NAC 687B to prohibit health insurers from imposing cost-sharing for new coronavirus (Covid-19) testing, provider visits for Covid-19 testing, and Covid-19 immunizations once available. The rule also requires health insurers to provide insureds and in-network providers with guidance regarding options for Covid-19 preventative measures and treatment. In addition, the rule requires health insurers to provide coverage for off-formulary prescription drugs if the formulary drug becomes unavailable. The rule is effective March 5, 2020, and expires July 3, 2020. Contact: Commissioner of Insurance; 775-687-0700
Texas Medical Facility Licensing, Occupational safety and health, Public Health 12/29/20 Emergency rule of the Health and Human Services Commission adopts regulations under 26 TAC 551 to establish requirements for intermediate care facilities for individuals with an intellectual disability (ICF/IID) to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; protocols for transferring Covid-19 positive residents to other facilities; screening of individuals, employees, and visitors; staffing policies; reporting of Covid-19 activity; and compliance with executive orders. The rule extends an Aug. 28, 2020, emergency rule. The rule is effective Dec. 11, 2020, and expires Feb. 9, 2021. Contact: Karen Ray; HHSC; 512-438-3161
New York Clinical Labs, Health Information and Technology, Insurance, Managed Care, Public Health 09/15/20 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule readopts a June 11, 2020, emergency rule. The rule is effective Sept. 9, 2020, and expires Nov. 9, 2020. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
Texas Medical Facility Licensing, Occupational safety and health, Public Health 03/01/21 Emergency rule of the Health and Human Services Commission adopts regulations under 26 TAC 551 to establish requirements for intermediate care facilities for individuals with an intellectual disability (ICF/IID) to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; protocols for transferring Covid-19 positive residents to other facilities; screening of individuals, employees, and visitors; staffing policies; reporting of Covid-19 activity; and compliance with executive orders. The rule replaces a Dec. 25, 2020, emergency rule. The rule is effective Feb. 10, 2021, and expires June 9, 2021. Contact: Karen Ray; HHSC; 512-438-3161
Oklahoma Health Information and Technology, Insurance, Medical Malpractice, Pharmaceuticals, Physicians 04/08/20 Notice of the Insurance Department announces amendments to Insurance Bulletin LH 2020-02, issued March 17, 2020, to health carriers and pharmacy benefit managers (PBMs) on the new coronavirus (Covid-19). Updates prohibit health carriers from requiring specific platforms for telemedicine services and request that medical professional liability insurers expand physicians' coverage. Health carriers now are required to take certain measures, including reviewing internal processes and continuity of operations, providing insureds access to accurate information, waiving cost-sharing for Covid-19 laboratory testing, ensuring robust telehealth programs, and waiving telehealth copayments. Carriers also are directed to verify the adequacy of their provider networks, expedite utilization review and appeal processes, expedite formulary exceptions, and identify and remove barriers to Covid-19 testing and treatment. In addition, carriers are prohibited from canceling coverage for those who are diagnosed with Covid-19 and unable to return to work or maintain current coverage for 90 days, and encouraged to extend to 60 days the grace period for nonpayment of premiums. Finally, the bulletin directs PBMs to cease audits during the public health emergency and to waive restrictions on pharmacies doing mail order, specifies that pharmacists writing “Covid-19” or similar language on a prescription is the equivalent of a signature, and allows a 60-day supply of prescriptions for maintenance drugs. The bulletin remains in effect for the duration of the emergency. Contact: Mike Rhoads; Insurance Department; 405-521-2828; mike.rhoads@oid.ok.gov
Oregon Clinical Labs, Medical Facility Licensing, Occupational safety and health, Pediatric Care, Public Health 07/31/20 Proposed rule of the Health Authority, Public Health Division, would amend regulations under OAR 333-017 , -018, and -019 to require health care providers to report coronavirus (Covid-19) cases, hospitalizations, and deaths and cases of multi-system inflammatory syndrome in children. The rule also would require laboratory reporting of positive and negative Covid-19 test results and require Covid-19 cases to be excluded from attendance or work in schools or children's facilities and from work in health care facilities or food service facilities. In addition, the rule would require health care facilities to adopt policies on restricting employees with Covid-19 or employees with substantial exposure to Covid-19. The proposal currently is in effect as a temporary rule. A hearing is scheduled for Aug. 21, 2020, via teleconference. Comments are due Aug. 26, 2020. Contact: Heather Owens; OHA, Public Health Division; 971-291-2568; heather.r.owens@dhsoha.state.or.us
Oklahoma Health Information and Technology, Insurance, Pharmaceuticals, Public Health 03/25/20 Notice of the Insurance Department announces Insurance Bulletin LH 2020-02 to health carriers and pharmacy benefit managers (PBMs) on the new coronavirus (Covid-19). Health carriers are asked to review their internal processes and continuity of operations, provide insureds access to accurate information, waive cost-sharing for Covid-19 testing, ensure their telehealth programs are robust, and waive telehealth copayments. Carriers also are asked to verify the adequacy of their provider networks, expedite utilization review and appeal processes, expedite formulary exceptions, and identify and remove barriers to Covid-19 testing and treatment. In addition, carriers are prohibited from canceling coverage for those who are diagnosed with Covid-19 and unable to return to work or maintain current coverage for 90 days and asked to extend to 60 days the grace period for nonpayment of premiums. Finally, the bulletin directs PBMs to cease audits during the public health emergency and to waive restrictions on pharmacies doing mail order, specifies that pharmacists writing “Covid-19” or similar language on a prescription is the equivalent of a signature, and allows a 60-day supply of prescriptions for maintenance drugs. The bulletin is dated March 17, 2020, and remains in effect for the duration of the emergency. Contact: Mike Rhoads; Insurance Department; 405-521-2828; mike.rhoads@oid.ok.gov
Texas Long-Term Care, Medical Facility Licensing, Occupational safety and health, Public Health 08/25/20 Emergency rule of the Health and Human Services Commission adopts regulations under 26 TAC 553 to establish requirements for assisted living facilities to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; protocols for transferring Covid-19 positive residents to other facilities; screening of residents, employees, and visitors; isolation of residents; staffing policies; wearing of face masks by staff; reporting of Covid-19 activity; and compliance with executive orders. The rule is effective Aug. 11, 2020, and expires Dec. 8, 2020. Contact: Karen Ray; HHSC; 512-438-3161
Georgia Health Information and Technology, Insurance, Medical Billing, Pharmaceuticals 03/11/20 Notice of the Office of Insurance and Safety Fire Commissioner announces the availability of Directive 20-EX-3 on coronavirus (Covid-19) preparations for health carriers. The directive requests that health carriers waive any cost-sharing for Covid-19 laboratory tests and consider options to reduce potential barriers of cost-sharing for testing and treatment of Covid-19 during the outbreak. The directive also provides that carriers should review and ensure their telehealth programs with participating providers will be able to meet any increased demand. In addition, the directive provides that carriers should make exceptions under certain circumstances to provide access to an out-of-network provider at the in-network cost-sharing, expedite utilization review and appeal processes for services related to Covid-19, when medically appropriate, and immediately cover future Covid-19 immunizations at no cost-sharing for all covered members. Finally, the bulletin provides that health carriers should ensure access to prescription drugs by making expedited formulary exceptions if needed and report to the department about actions taken in response to the bulletin. Contact: Office of Insurance and Safety Fire Commissioner; 404-656-2056
Texas Long-Term Care, Medical Facility Licensing, Occupational safety and health, Public Health 12/21/20 Emergency rule of the Health and Human Services Commission adopts regulations under 26 TAC 553 to establish requirements for assisted living facilities to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; protocols for transferring Covid-19 positive residents to other facilities; screening of residents, employees, and visitors; isolation of residents; staffing policies; wearing of face masks by staff; reporting of Covid-19 activity; and compliance with executive orders. The rule extends an Aug. 21, 2020, emergency rule, which now expires Feb. 6, 2021. Contact: Karen Ray; HHSC; 512-438-3161
New York Clinical Labs, Insurance, Public Health 04/03/20 Emergency rule of the Department of Financial Services amends regulations under 13 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests necessary to diagnose the new coronavirus (Covid-19). The rule prohibits insurers that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule is effective March 13, 2020, and expires June 10, 2020. Contact: Tobias Len; DFS; 518-474-8975; Tobias.Len@dfs.ny.gov
New York Health Information and Technology, Insurance, Managed Care, Public Health 06/16/20 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule readopts a March 13, 2020, emergency rule. The rule is effective June 11, 2020, and expires Sept. 9, 2020. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
Texas Medical Facility Licensing, Occupational safety and health, Public Health 09/01/20 Emergency rule of the Health and Human Services Commission adopts regulations under 26 TAC 551 to establish requirements for intermediate care facilities for individuals with an intellectual disability (ICF/IID) to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; protocols for transferring Covid-19 positive residents to other facilities; screening of individuals, employees, and visitors; staffing policies; reporting of Covid-19 activity; and compliance with executive orders. The rule is effective Aug. 14, 2020, and expires Dec. 11, 2020. Contact: Karen Ray; HHSC; 512-438-3161
New York Clinical Labs, Health Information and Technology, Insurance, Managed Care, Public Health 04/13/21 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule extends a Jan. 7, 2021, emergency rule. The rule is effective April 5, 2021, and expires May 4. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
Colorado Health Information and Technology, Insurance, Pharmaceuticals, Public Health 03/24/20 Notice of the Department of Regulatory Agencies, Division of Insurance, announces the issuance of Bulletin No. B-4.104 regarding insurance coverage of coronavirus (Covid-19) claims. The bulletin advises insurers of a March 17, 2020, emergency rule that establishes the coverage and cost-sharing requirements for commercial insurance carriers related to claims arising from testing and treatment of Covid-19. The bulletin also directs insurers to provide coverage for telehealth services, testing, and in-network visits without cost-sharing when covered individuals seek testing for Covid-19. In addition, the bulletin requires carriers to cover out-of-network testing services if an in-network provider is unavailable and at least one additional early refill of all necessary prescriptions under normal cost-sharing amounts. Finally, the bulletin addresses the state's public health criteria for patients to be tested for Covid-19. The bulletin is dated March 9, 2020. Contact: DORA, Division of Insurance; 303-894-7490
Nevada Insurance, Managed Care, Pharmaceuticals, Public Health 06/04/20 Notice of the Commissioner of Insurance announces revisions to a May 19, 2020, proposed rule that would adopt regulations under NAC 687B to prohibit health insurers from imposing cost-sharing for coronavirus (Covid-19) testing, provider visits for Covid-19 testing, and Covid-19 immunizations once available. The rule also would require health insurers to provide insureds and in-network providers with information on options for Covid-19 preventative measures and treatment. In addition, the rule would require health insurers to provide coverage for off-formulary prescription drugs if the formulary drug becomes unavailable. The revisions clarify language regarding office visits and coverage of vaccines. The proposal currently is in effect as an emergency rule, expiring July 3, 2020. A comment due date is not specified. Contact: Commissioner of Insurance; 775-687-0700
New York Clinical Labs, Health Information and Technology, Insurance, Managed Care, Public Health 12/02/20 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule readopts a June 11, 2020, emergency rule. The rule is effective Nov. 9, 2020, and expires Jan. 8, 2021. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
New York Clinical Labs, Health Information and Technology, Insurance, Managed Care, Public Health 01/12/21 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule readopts a Sept. 9, 2020, emergency rule. The rule is effective Jan. 7, 2021, and expires March 5, 2021. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
New York Clinical Labs, Health Information and Technology, Insurance, Managed Care, Public Health 03/12/21 Emergency rule of the Department of Financial Services amends regulations under 11 NYCRR 52 to waive cost-sharing for in-network visits and laboratory tests to diagnose the coronavirus (Covid-19). The rule prohibits health care plans that provide hospital, surgical, or medical expense insurance policies or contracts from imposing copayments, coinsurance, or annual deductibles for covered in-network laboratory tests to diagnose Covid-19 and for visits to diagnose Covid-19, including through telehealth. The rule applies to in-network provider offices, in-network urgent care centers, any other in-network outpatient provider setting able to diagnose Covid-19, and emergency departments of hospitals. The rule also requires insurers to provide written notification of the requirements to in-network providers. The rule readopts a Jan. 7, 2021, emergency rule. The rule is effective March 5, 2021, and expires April 4, 2021. Contact: Tobias Len; DFS; 518-474-8975; tobias.len@dfs.ny.gov
Nevada Insurance, Managed Care, Pharmaceuticals, Public Health 05/27/20 Proposed rule of the Commissioner of Insurance would adopt regulations under NAC 687B to prohibit health insurers from imposing cost-sharing for coronavirus (Covid-19) testing, provider visits for Covid-19 testing, and Covid-19 immunizations once available. The rule also would require health insurers to provide insureds and in-network providers with guidance regarding options for Covid-19 preventative measures and treatment. In addition, the rule would require health insurers to provide coverage for off-formulary prescription drugs if the formulary drug becomes unavailable. The rule is currently in effect as an emergency rule, expiring July 3, 2020. A comment due date is not specified. Contact: Commissioner of Insurance; 775-687-0700
Massachusetts Clinical Labs, Managed Care, Medicaid, Medical Billing, Public Health 08/24/20 Notice of the Executive Office of Health and Human Services announces Managed Care Entity Bulletin 40 to clarify requirements for payment for coronavirus (Covid-19) specimen collection when providers also conduct or bill for the laboratory test. The bulletin also requires managed care plans to allow the use of modifier CG by providers; to cover all medically necessary laboratory testing for Covid-19; and to pay for medically necessary specimen collection, testing, and resulting services. Contact: MassHealth; 800-841-2900; providersupport@mahealth.net
Mississippi Pharmaceuticals, Public Health 03/27/20 Notice of the Board of Pharmacy provides information to pharmacists and prescribers regarding chloroquine and hydroxychloroquine used to treat new coronavirus (Covid-19). The board advises pharmacists and prescribers that the FDA has not approved use of these drugs for Covid-19 prophylaxis and that their use for such treatment should be restricted to patients who are admitted to hospitals with Covid-19 infections. The board also advises pharmacists to use professional judgment when filling prescriptions and that pharmacists may deny prescriptions. Contact: Board of Pharmacy; 601-899-8880
California Emergency Care, Health Information and Technology, Managed Care, Medicaid, Medical Billing, Public Health 03/12/20 Notice of the Department of Managed Health Care announces the issuance of an all-plan letter (APL-20-006) on cost-sharing reductions for consumers to receive medically necessary screening and testing for the new coronavirus (Covid-19). The letter directs all full-service commercial and Medi-Cal health care service plans to reduce cost-sharing to zero for all medically necessary screening and testing for Covid-19, including hospital, emergency department, urgent care, and provider office visits where the purpose of the visit is to be screened or tested for Covid-19. The letter also directs insurers to notify their staff, their contracted providers, and the public about the cost-sharing waiver and provide information about the best ways to access care for the screening and treatment of Covid-19. In addition, the letter addresses requirements for insurers to provide timely access to care and encourages the proactive use of telehealth and the waiver of prior authorization for drugs prescribed in lieu of a drug experiencing a shortage. The letter is dated March 5, 2020. Contact: Sarah Ream; DMHC; 916-324-8176
Missouri Occupational safety and health, Public Health 02/23/21 Emergency rule of the Department of Health and Senior Services adopts regulations under 19 CSR 20-20 to establish procedures for the Covid-19 Vaccine Priority Tier Evaluation Committee, which will assess requests from employers having special circumstances that may justify a reclassification of their assigned vaccine priority tier in response to the coronavirus (Covid-19) outbreak. The rule is effective Feb. 25, 2021, and expires Aug. 23, 2021. Contact: DHSS, Division of Community and Public Health; 573-751-6080
Oregon Clinical Labs, Public Health 04/02/20 Temporary rule of the Health Authority, Public Health Division, adopts regulations under OAR 333-018 to require laboratories and health care providers to report both positive and negative tests for new coronavirus (Covid-19). The rule also requires the reporting of individuals with Covid-19 who are hospitalized and deaths from Covid-19 and requires the submission of reports through an electronic case reporting portal. The rule, which replaces in part a March 10, 2020, temporary rule, is effective March 30, 2020, and expires Sept. 4, 2020. Contact: Brittany Hall; OHA, Public Health Division; 971-673-1111; publichealth.rules@state.or.us
Florida Emergency Care, Health Practitioner Licensing, Pharmaceuticals, Public Health 02/19/21 Emergency rule of the Department of Health adopts regulations under FAC 64JER21-1 to allow certified paramedics acting under medical direction to prepare and administer coronavirus (Covid-19) vaccines and to supervise emergency medical technicians (EMTs) administering Covid-19 vaccines. The rule also allows certified EMTs acting under medical direction or supervision of a paramedic or other authorized health care practitioner to administer prepared Covid-19 vaccines. In addition, the rule requires paramedics and EMTs to complete associated training and comply with established protocols. The rule is effective Feb. 16, 2021, and expires May 17, 2021. Contact: Melia Jenkins; DOH; 850-558-9532; melia.jenkins@flhealth.gov
Massachusetts Health Information and Technology, Insurance, Public Health 04/01/20 Notice of the Office of Consumer Affairs and Business Regulation, Division of Insurance, announces Bulletin 2020-07 to notify health insurance carriers of the division's expectation that the carriers assist in protecting public health and pharmacy staff during the new coronavirus (Covid-19) public health crisis. The division expects carriers to educate consumers about Covid-19, methods to prevent its spread, how to access benefits and services for Covid-19, and how to use the carriers' telehealth platform. The division also expects carriers to establish resources to address consumer inquiries, guidelines for appeals and grievances, and means of staying in contact with consumers to avoid disruptions in service. Contact: Kevin Beagan; Division of Insurance, Health Care Access Bureau; 617-521-7323
Kentucky Health Care Workforce, Long-Term Care, Public Health 04/28/20 Notice of the Department of Insurance announces a guidance for health care professionals, those seeking clearance from isolation, and those returning to confined population environments during the coronavirus (Covid-19) pandemic. The guidance specifies that individuals with symptomatic, laboratory-confirmed Covid-19 or clinically suspected Covid-19 should remain in isolation until meeting certain criteria and should wear a face mask upon return to work. The guidance also addresses work practices and restrictions, requirements specific to employees of health care facilities, and the return of residents with confirmed cases to confined population environments. Contact: Department of Insurance; 800-595-6053
Texas Long-Term Care, Medical Facility Licensing, Occupational safety and health, Public Health 12/21/20 Emergency rule of the Health and Human Services Commission adopts regulations under 40 TAC 19 to establish requirements for nursing facilities to mitigate and contain the coronavirus (Covid-19). The rule sets forth requirements for Covid-19 response plans; screening of residents, staff, and contractors; isolation of residents; staffing policies; wearing of face masks by staff; reporting of Covid-19 activity; and compliance with executive orders. The rule extends an Aug. 21, 2020, emergency rule, which now expires Feb. 1, 2021. Contact: Karen Ray; HHSC; 512-438-3161
Kentucky Insurance, Managed Care, Public Health 05/01/20 Notice of the Department of Insurance announces a guidance on hospital services during the coronavirus (Covid-19) state of emergency. The guidance prohibits insurers from requiring preauthorization for the transfer of patients via ambulance to other facilities for the purpose of transferring a patient not diagnosed with Covid-19 to make a bed available for a patient diagnosed with Covid-19. The guidance also requires suspension of preauthorization and concurrent review for all inpatient services. In addition, the guidance specifies that audit activities, recoupments, and appeal time frames for appeals of post-service claims for inpatient services are suspended. The document further encourages insurers to consider expediting credentialing for providers, providing billing guidance, and working with hospitals by advancing claim payments. The guidance is effective through May 27, 2020. Contact: Department of Insurance; 800-595-6053
Alaska Health Information and Technology, Insurance, Public Health 03/11/20 Notice of the Department of Commerce, Community, and Economic Development announces the issuance of Bulletin 20-04 to insurers concerning the new coronavirus (Covid-19). The bulletin requires insurers to waive any in-network and out-of-network cost-sharing responsibility for laboratory diagnostic testing for respiratory syncytial virus, influenza, respiratory panel tests, and Covid-19 and requests that insurers also waive cost-sharing for office, urgent care center, or emergency department visits related to such testing. The bulletin also encourages insurers to liberalize telehealth benefit provision during the period of increased infection and to review and ensure that telehealth programs can meet increased demand. The bulletin further encourages health insurers to identify and remove barriers to testing and treatment for Covid-19. The bulletin is dated March 6, 2020, and is effective through April 30, 2020. Contact: Sarah Bailey; DCCED, Division of Insurance; 907-465-4608; sarah.bailey@alaska.gov
Maryland Insurance, Public Health 04/03/20 Notice of the Insurance Administration announces Bulletin 20-06 to health insurers on emergency regulations that amend requirements during the new coronavirus (Covid-19) outbreak. Health insurers are required to waive cost-sharing, copayment, coinsurance, and deductibles for Covid-19 testing, laboratory fees, and vaccinations. Health insurers are also required to consider certain factors when evaluating requests to use out-of-network testing providers. Health insurers are only allowed to evaluate medical necessity of Covid-19 testing for the purposes of prior authorization. The bulletin is dated March 13, 2020. Contact: Insurance Administration, Life and Health Unit; 410-468-2170
Delaware Health Information and Technology, Insurance, Public Health 03/24/20 Notice of the Department of Insurance announces the issuance of Domestic and Foreign Insurers Bulletin No. 116 to provide additional guidance on the new coronavirus (Covid-19). The bulletin, which follows Bulletin 115 of March 5, 2020, requests that carriers suspend cancellations and nonrenewals due to nonpayment of premiums during the governor's declared state of emergency, fully reimburse all telemedicine and telehealth services, and waive all pre-authorization requirements for lab testing and treatment for Covid-19. The bulletin also specifies that the department will not take enforcement action against any health insurance issuer that amends its catastrophic plans to provide pre-deductible coverage for services associated with diagnosis or treatment of Covid-19. Contact: Trinidad Navarro; Department of Insurance; 302-674-7300
Texas Health Information and Technology, Insurance, Medical Billing, Public Health 03/13/20 Notice of the Department of Insurance announces the issuance of Commissioner's Bulletin B-0005-20 to health insurers and health maintenance organizations regarding coronavirus (Covid-19) testing and prevention. The bulletin encourages insurers to take certain actions to prevent, test, and treat Covid-19, such as waiving copayments, co-insurance, and deductibles for testing; waiving cost-sharing and facilitating expanded use of telemedicine; and allowing extra time for providers and facilities to file claims. The bulletin also urges insurers to report such actions to the department. The bulletin is dated March 11, 2020. Contact: TDI; 800-578-4677; COVID19Response@tdi.texas.gov
Hawaii Insurance, Public Health 05/01/20 Notice of the Department of Commerce and Consumer Affairs, Insurance Division, announces Memorandum 2020-4A to insurers on waivers of certain requirements during the coronavirus (Covid-19) public health emergency. The agency provides information on activities that will not be considered unfair trade practices or unfair methods of competition, claims handling measures that are supported to promote consumer protection to prevent the spread of Covid-19, and insurer proposals that may be considered to limit risk exposure to Covid-19. The memorandum is dated April 27, 2020. Contact: DCCA, Insurance Division; 808-586-2790
Colorado Health Information and Technology, Insurance, Managed Care, Pharmaceuticals, Public Health 04/09/21 Emergency rule of the Department of Regulatory Agencies, Division of Insurance, adopts regulations under 3 CCR 702-4 to establish coverage and cost sharing requirements for claims related to testing and treatment of the coronavirus (Covid-19). The rule also adds requirements for access to prescription drugs during the Covid-19 public health emergency. The rule, which replaces a Nov. 18, 2020, emergency rule, updates the coverage and cost sharing requirements for Covid-19 claims. The rule is effective March 19, 2021, and expires July 17, 2021. Contact: Christine Gonzales-Ferrer; DORA, Division of Insurance; 303-894-2157; christine.gonzales-ferrer@state.co.us
North Carolina Health Practitioner Licensing, Nurses, Pharmaceuticals, Physicians, Public Health 07/21/20 Temporary rule of the Medical Board amends regulations under 21 NCAC 32B and 32M to establish an expedited process for physicians and physician assistants with inactive medical licenses to obtain a temporary emergency license during the coronavirus (Covid-19) pandemic. The rule also establishes a Covid-19 restricted drug list and standards for physicians or physicians assistants and nurse practitioners to prescribe restricted drugs for the treatment of Covid-19. The rule is effective June 26, 2020, and expires March 23, 2021. Contact: Lynne Taylor; Medical Board; 919-326-1100; lynne.taylor@ncmedboard.org
Oregon Pharmaceuticals, Public Health 04/07/20 Temporary rule of the Board of Pharmacy adopts regulations under OAR 855-007 to prohibit the dispensing of chloroquine and hydroxychloroquine for presumptive treatment or prevention of coronavirus disease (Covid-19) infections. The rule allows patients who are hospitalized with a positive test result or clinical diagnosis of a Covid-19 infection to be prescribed chloroquine and hydroxychloroquine. The rule is intended to preserve drug supplies for the treatment of malaria, inflammatory conditions, and documented Covid-19 infections in hospitalized patients. The rule revises a March 25, 2020, temporary rule. The rule is effective April 2, 2020, and expires Sept. 20, 2020. Contact: Rachel Melvin; Board of Pharmacy; 971-673-0001; pharmacy.rulemaking@oregon.gov
West Virginia Health Information and Technology, Pharmaceuticals 05/05/20 Emergency rule of the Board of Pharmacy amends and adopts regulations under 15 WVCSR 1 to implement Drug Enforcement Administration exceptions to Schedule II controlled substances prescribing requirements in response to the coronavirus (Covid-19) pandemic. The rule allows practitioners 15 days to provide an original prescription for emergency oral prescriptions and specifies acceptable methods for delivery, including electronically. The rule also limits prescriptions of chloroquine and hydroxychloroquine in response to a shortage of the drugs due to their potential for use in treatment of Covid-19. In addition, the rule defines activities that are not “compounding” to distinguish between compounding and combining prescriptions. Portions of the rule replace an April 1, 2020, emergency rule, and are in effect for the duration of the Covid-19 pandemic. The rule is effective April 30, 2020. Contact: Ryan Hatfield; Board of Pharmacy; 304-208-3145; ryan.l.hatfield@wv.gov
Alaska Health Information and Technology, Insurance, Medical Billing, Public Health 03/24/20 Notice of the Department of Commerce, Community, and Economic Development announces the issuance of Bulletin 20-09 to insurers concerning the new coronavirus (Covid-19). The bulletin, which supersedes Bulletin 20-04, revises and adds provisions to clarify that respiratory panel tests are no longer subject to zero cost-sharing requirements. The bulletin also clarifies that high deductible health plans will not lose such status from covering Covid-19 testing costs prior to meeting plan deductibles and that health insurers are prohibited from requiring prior authorization or other medical management techniques for Covid-19 testing, products, items, and services. The bulletin is dated March 19, 2020. Contact: Sarah Bailey; DCCED, Division of Insurance; 907-465-4608; sarah.bailey@alaska.gov
Massachusetts Health Information and Technology, Home Care, Medicaid, Pharmaceuticals, Physicians 03/26/20 Notice of the Executive Office of Health and Human Services announces Administrative Bulletin 20-09 to acute care hospitals and community health centers that are Health Safety Net providers. The bulletin specifies the codes that providers should use to billing for the testing, treatment, and prevention of Coronavirus (Covid-19), including diagnostic laboratory services, telehealth, home visits, quarantine, and drugs. The bulletin also describes an expansion of hospital-determined presumptive eligibility procedures for individuals diagnosed with Covid-19. In addition, the bulletin addresses the lack of cost-sharing and primary care referral requirements for Covid-19 services and allows enrollees to receive 90-day supplies and early refills of necessary prescriptions. The bulletin is issued in response to the March 10, 2020, state of emergency declaration and reflects agency's guidance for MassHealth providers. The bulletin is effective March 12, 2020. Contact: EOHHS, Health Safety Net; 800-609-7232; HSNHelpdesk@state.ma.us
New Mexico Medical Malpractice, Public Health 12/16/20 Notice of the Patients' Compensation Fund announces that, in response to the coronavirus (Covid-19) pandemic, medical malpractice policies cannot exclude, limit, or modify claims against any qualified health care provider arising from the diagnosis, misdiagnosis, failure to diagnose, treatment, or failure to treat Covid-19. The notice also specifies that no such insurer can deny malpractice coverage for a qualified health care provider who performs medical services in a different specialty rating as a result of Covid-19 exigencies or health care provider shortages. Contact: Sandra Romero; PCF; 505-827-4385; sandrar.romero@state.nm.us
Massachusetts Long-Term Care, Medicaid 04/20/20 Notice of the Executive Office of Health and Human Services announces Administrative Bulletin 20-19 to provide temporary per diem rates and supplemental payments for nursing facilities providing coronavirus (Covid-19) services during the public health emergency. The updated rates and methodologies are intended to support the establishment of dedicated Covid-19 nursing facilities to care for Covid-19 residents. The rates will be in effect for the duration of the public health emergency. The bulletin is effective April 16, 2020. Comments are due April 30, 2020. Contact: Meera Ramamoorthy; EOHHS; 617-573-1600; Meera.Ramamoorthy@state.ma.us
New Mexico Insurance, Medical Billing, Pharmaceuticals 03/26/20 Notice of the Office of Superintendent of Insurance announces Bulletin 2020-004 to health insurers regarding preparation for the potential spread of new coronavirus (Covid-19). The office urges health insurers to take certain actions to prepare and educate their company, consumers, and network providers. For example, the office advises insurers to ensure their systems and those of network providers can bill and process the new Covid-19 billing codes and ensure that insureds who may be in a Covid-19 waiting period of self-isolation can obtain a one-time refill of their covered prescription medications prior to expiration of the normal refill waiting period. The bulletin is dated March 6, 2020. Contact: Russell Toal; OSI; 505-827-4601
of 20 Next
Per Page